Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Antoniou

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
The European Respiratory Journal|October 27, 2012
The pathogenesis of pulmonary fibrosis: a moving targetWim A Wuyts, Carlo Agostini, Katerina M Antoniou, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Interstitial Lung Diseases AssemblySabina A Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, et al.
The European Respiratory Journal|March 11, 2021
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineJames D Chalmers, Megan L Crichton, Pieter C Goeminne, et al.
The European Respiratory Journal|June 16, 2022
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineNicolas Roche, Megan L Crichton, Pieter C Goeminne, et al.
International Archives of Allergy and Immunology|June 23, 2020
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim AnalysisMaria Kallieri, Eleftherios Zervas, Konstantinos Katsoulis, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Cell Reports. Medicine|May 1, 2026
An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosisAlexios N Matralis, Elli-Anna Stylianaki, Eleni M Ladopoulou, et al.
Rheumatology Advances in Practice|June 10, 2024
<i>RPA3-UMAD1</i> rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestryPierre-Antoine Juge, Jeffrey A Sparks, Steven Gazal, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
The European Respiratory Journal|October 27, 2012
The pathogenesis of pulmonary fibrosis: a moving targetWim A Wuyts, Carlo Agostini, Katerina M Antoniou, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Interstitial Lung Diseases AssemblySabina A Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, et al.
The European Respiratory Journal|March 11, 2021
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineJames D Chalmers, Megan L Crichton, Pieter C Goeminne, et al.
The European Respiratory Journal|June 16, 2022
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineNicolas Roche, Megan L Crichton, Pieter C Goeminne, et al.
International Archives of Allergy and Immunology|June 23, 2020
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim AnalysisMaria Kallieri, Eleftherios Zervas, Konstantinos Katsoulis, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Cell Reports. Medicine|May 1, 2026
An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosisAlexios N Matralis, Elli-Anna Stylianaki, Eleni M Ladopoulou, et al.
Rheumatology Advances in Practice|June 10, 2024
<i>RPA3-UMAD1</i> rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestryPierre-Antoine Juge, Jeffrey A Sparks, Steven Gazal, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Pageof 24